The purpose of the recommended approaches is to help stakeholders develop highly effective, evidence-based, drug-drug interaction (DDI) clinical decision support. The recommended approaches are intended to be reflective of the best evidence currently available.
Advanced authoring of drug–drug Interaction clinical decision support: the Drug Interaction Customize Editor (DICE) tool This video provides an overview of a novel drug interaction clinical decision support editing user interface
Recommendations for selecting drug–drug Interactions for clinical decision support This paper describes recommendations by a work group to create a process to establish a standard set of DDIs for clinical decision support.
Consensus recommendations for systematic evaluation of drug–drug interaction evidence for clinical decision support This paper provides recommendations for systematic evaluation of evidence from the scientific literature, drug product labeling, and regulatory documents with respect to DDIs for clinical decision support.
Recommendations to improve the usability of drug-drug interaction clinical decision support alerts This paper establishes preferred strategies for presenting DDI clinical decision support alerts.
A minimum information model for the representation of potential drug-drug interaction knowledge and evidence This report provides recommendations for a minimum information model for information about potential DDIs.